IDRA

Idera Pharmaceuticals Stock Price

1.025
-0.025 (-2.38%)
Upgrade to Real-Time
Regular Market
1.025

Low
0.971

52 Week Range

High
6.14

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Idera Pharmaceuticals Inc IDRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.025 -2.38% 1.025 13:49:13
Open Price Low Price High Price Close Price Prev Close
1.05 1.02 1.05 1.05
Bid Price Ask Price Spread News
1.02 1.03 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
675 192,661 $ 1.03 $ 199,257 - 0.971 - 6.14
Last Trade Time Type Quantity Stock Price Currency
13:49:17 2 $ 1.025 USD

Period:

Draw Mode:

Idera Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 51.28M 50.03M 39.41M $ - $ - -3.33 -0.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 374.91k 4.00%

more financials information »

Idera Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IDRA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.011.080.9951.04599,9190.0151.49%
1 Month1.311.320.98411.151,228,442-0.285-21.76%
3 Months1.191.710.9711.362,576,112-0.165-13.87%
6 Months5.986.120.9711.752,764,527-4.96-82.86%
1 Year2.456.140.9711.951,520,459-1.43-58.16%
3 Years6.9810.950.8132.50702,020-5.96-85.32%
5 Years13.1226.640.8139.911,008,022-12.10-92.19%

Idera Pharmaceuticals Description

Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases. The company has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates.


Your Recent History
NASDAQ
IDRA
Idera Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.